Volume 1 2012

Neuroblastoma

Diagnosis, Therapy, and Prognosis

Editors:

ISBN: 978-94-007-2417-4 (Print) 978-94-007-2418-1 (Online)

Table of contents (24 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xviii

  2. Introduction

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-7

      Introduction

  3. Diagnosis and Biomarkers

    1. Front Matter

      Pages 9-9

    2. No Access

      Book Chapter

      Pages 11-20

      Pediatric CNS Neuroblastoma: Magnetic Resonance Imaging and Spectroscopy

    3. No Access

      Book Chapter

      Pages 21-29

      Pediatric Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome: Early Diagnosis

    4. No Access

      Book Chapter

      Pages 31-38

      Neuroblastoma Mouse Model

    5. No Access

      Book Chapter

      Pages 39-45

      Orbital Metastasis in Neuroblastoma Patients

    6. No Access

      Book Chapter

      Pages 47-63

      Pediatric Neuroblastoma: Molecular Detection of Minimal Residual Disease

    7. No Access

      Book Chapter

      Pages 65-75

      A Comprehensive Tissue Microarray-Based FISH Screen of ALK Gene in Neuroblastomas

  4. Therapy

    1. Front Matter

      Pages 77-77

    2. No Access

      Book Chapter

      Pages 79-90

      Neuroblastoma: Triptolide Therapy

    3. No Access

      Book Chapter

      Pages 91-103

      Neuroblastoma: Ornithine Decarboxylase and Polyamines are Novel Targets for Therapeutic Intervention

    4. No Access

      Book Chapter

      Pages 105-113

      Neuroblastoma: Antibody-Based Immunotherapy

    5. No Access

      Book Chapter

      Pages 115-123

      Targeting Multidrug Resistance in Neuroblastoma

    6. No Access

      Book Chapter

      Pages 125-135

      Neuroblastoma: Perspectives for the Use of IL-21 in Immunotherapy

    7. No Access

      Book Chapter

      Pages 137-149

      Neuroblastoma: Role of Hypoxia and Hypoxia Inducible Factors in Tumor Progression

    8. No Access

      Book Chapter

      Pages 151-159

      Neuroblastoma: Role of GATA Transcription Factors

    9. No Access

      Book Chapter

      Pages 161-167

      Neuroblastoma: Role of MYCN/Bmi1 Pathway in Neuroblastoma

    10. No Access

      Book Chapter

      Pages 169-176

      Neuroblastoma: Role of Clusterin as a Tumor Suppressor Gene

    11. No Access

      Book Chapter

      Pages 177-183

      Refractory Neuroblastoma Cells: Statins Target ATP Binding Cassette-Transporters

    12. No Access

      Book Chapter

      Pages 185-198

      Neuroblastoma: Dosimetry for MIBG Therapies

    13. No Access

      Book Chapter

      Pages 199-207

      Advanced Neuroblastoma: Role of ALK Mutations

    14. No Access

      Book Chapter

      Pages 209-214

      Pediatric Neuroblastoma: Treatment with Oral Irinotecan and Temozolomide

previous Page of 2